RPT-DEALTALK-Canadian cannabis producers set their sights high

Fri Jun 13, 2014 7:00am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(Repeats story originally published overnight)

By John Tilak

TORONTO, June 13 (Reuters) - By unlocking the once-obscure medical marijuana market, Canada has created a fast-growing, profitable and federally regulated industry with a distinct appeal to the more daring global investor.

About a dozen producers of the drug will find themselves in the spotlight this year as they consider going public or prepare to so through share sales or reverse takeovers to capitalize on recent regulatory changes, investment bankers said.

The Canadian companies are in a race to raise money to build facilities, attract patients and grab shares in a market projected to grow to C$1.3 billion ($1.20 billion) in the next 10 years.

Despite facing considerable risks, they have the advantage of being in one of the few countries where medical marijuana is legal nationwide and where licensed operators can mass-produce it.

In the United States, the drug remains illegal at the federal level. Some 20 U.S. states have legalized medical marijuana, but investors worry about the prospect, however remote, that the federal government may strike down those laws.

Although the U.S. market is home to companies including Medical Marijuana Inc and Cannabis Science Inc , their northern counterparts are likely to benefit from greater legitimacy and legal clarity. Sources said much of the private equity investment in the Canadian industry had come from the United States.

"Canada is one of the few countries anywhere where its citizens have a constitutionally protected right to access medical marijuana with a physician's consent," said Paul Rosen, chief executive officer of PharmaCan, a holding company with large stakes in four producers. "And you've got the government trying to create an industry around it."   Continued...